HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The feasibility of patient-controlled paravertebral analgesia for major breast cancer surgery: a prospective, randomized, double-blind comparison of two regimens.

AbstractBACKGROUND:
Paravertebral analgesia is useful for breast surgery. Patient controlled analgesia by IV or epidural routes is well established for delivering postoperative analgesia. Our objective was to apply patient control to paravertebral analgesia and evaluate the efficacy and tolerability of two distinct dosing regimens.
METHODS:
Patients undergoing major breast cancer surgery were recruited for this prospective, double-blind, randomized trial of two patient-controlled paravertebral analgesia regimens: 19 patients received levobupivacaine 0.2% at 8 mL/h with 3-mL bolus and 15-min lockout (15-min lockout group); 18 received levobupivacaine 0.2% at 4 mL/h with 8-mL bolus and 30-min lockout (30-min lockout group). Our primary outcome was dynamic pain scores (visual analog scale) at 4-hourly intervals for 36 h. Secondary outcomes were resting pain scores, rescue analgesia requirements, volume of levobupivacaine administered, demands for levobupivacaine, levobupivacaine boluses received, and patient satisfaction.
RESULTS:
Resting and dynamic pain scores were comparable in the groups. Two 15-min lockout patients and five 30-min lockout patients required rescue analgesia (P = 0.23). Patients received 400 +/- 95 mL and 330 +/- 130 mL levobupivacaine in 15-min and 30-min lockout groups, respectively (P = 0.012). The 15-min lockout group requested a bolus 75 +/- 16 times; the 30-min lockout group requested it 69 +/- 14 times (P = 0.40). However, the 15-min lockout group received 39 +/- 22 boluses and the 30-min lockout group only 24 +/- 16 (P = 0.02). Systolic pressure, heart rate, respiratory rate, sedation scores, nausea, antiemetic requirement, and satisfaction scores were similar in each group.
CONCLUSIONS:
Patient-controlled paravertebral analgesia for breast cancer surgery, with either regimen, provided satisfactory analgesia and was well tolerated.
AuthorsJennifer McElwain, Noelle M Freir, Crina L Burlacu, Denis C Moriarty, Daniel I Sessler, Donal J Buggy
JournalAnesthesia and analgesia (Anesth Analg) Vol. 107 Issue 2 Pg. 665-8 (Aug 2008) ISSN: 1526-7598 [Electronic] United States
PMID18633050 (Publication Type: Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anesthetics, Local
  • Levobupivacaine
  • Bupivacaine
Topics
  • Analgesia, Epidural
  • Analgesia, Patient-Controlled (methods)
  • Anesthetics, Local (administration & dosage)
  • Breast Neoplasms (surgery)
  • Bupivacaine (administration & dosage, analogs & derivatives)
  • Double-Blind Method
  • Female
  • Humans
  • Levobupivacaine
  • Middle Aged
  • Pain, Postoperative (therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: